查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1704295

2025年癲癇發作治療全球市場報告

Epileptic Seizures Treatment Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年癲癇發作治療市場規模將強勁成長。到 2029 年，這一數字將成長至 47.2 億美元，複合年成長率為 6.6%。預測期內的成長將歸因於精準醫療方法、新興治療方式、遠端醫療和遠端監控、醫療保健整合和多學科護理以及監管支持和獎勵。預測期內的關鍵趨勢包括個人化醫療、數位健康解決方案的整合、新的治療方法、關注合併症和生活品質、監管支持和市場進入。

癲癇盛行率的不斷上升預計將推動癲癇發作治療市場的未來成長。癲癇是一種神經系統疾病，其特徵是反覆無誘因的癲癇發作，由大腦異常電活動引起，可導致多種症狀，包括抽搐、意識喪失以及感覺和行為障礙。導致癲癇盛行率上升的因素包括腦損傷和中風患者的存活率提高以及老齡人口的增加。有效治療癲癇發作，主要使用抗癲癇藥物（AED），可顯著減少癲癇發作的頻率和嚴重程度，從而確保患者的日常生活和整體健康。例如，根據世界衛生組織（WHO）的數據，截至2024年2月，全球約有5,000萬名癲癇患者，每年約有500萬新診斷的癲癇病例。因此，癲癇發生率的不斷上升刺激了癲癇治療市場的擴張。

癲癇發作治療市場的關鍵參與者正在創新，開拓大麻類藥物等替代治療方案，特別是針對對傳統抗癲癇藥物沒有反應的患者。大麻類藥物源自大麻植物，利用大麻素的治療特性，主要透過其抗驚厥作用來治療多種疾病，包括癲癇。例如，2024 年 1 月，Aqumentis Healthcare Limited 推出了 Cracepi，這是一種從植物來源植物中提取的口服藥物，經印度藥品管理總局核准，用於治療兒童癲癇發作，特別是腸漏症候群。 Crassepidemi 的四氫大麻酚 (THC) 含量極少，已被證明能有效減少癲癇發作，尤其是在常規治療無效的情況下。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、感染疾病、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球癲癇發作治療PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球癲癇治療市場：成長率分析
  • 全球癲癇發作治療市場表現：規模與成長，2019-2024 年
  • 全球癲癇治療市場預測：2024-2029年及2034年規模與成長
  • 全球癲癇發作治療總目標市場（TAM）

第6章市場區隔

  • 全球癲癇發作治療市場類型、表現及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 治療實踐
  • 新興藥物
  • 個人化治療
  • 全球癲癇發作治療市場（按發作類型、表現和預測）2019-2024 年、2024-2029 年、2034 年
  • 局部性癲癇
  • 全身性癲癇
  • 無法分類的癲癇發作
  • 全球癲癇治療市場依給藥途徑、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 口服或頰用
  • 鼻腔
  • 直腸
  • 腸外
  • 全球癲癇發作治療市場依通路、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院藥房
  • 零售藥局
  • 網路藥局
  • 全球癲癇發作治療市場，按治療實踐細分，按類型、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 抗癲癇藥物（AED）
  • 外科手術
  • 迷走神經刺激（VNS）
  • 生酮飲食
  • 反應性神經刺激（RNS）
  • 全球癲癇治療市場，依新藥類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 新型抗癲癇藥物
  • 大麻二酚類藥物
  • 基於基因治療的治療
  • 單株抗體
  • 全球癲癇發作治療市場，依個別治療類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 單藥治療
  • 聯合治療
  • 輔助性治療

第7章 區域和國家分析

  • 全球癲癇治療市場各地區表現及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 全球癲癇治療市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 癲癇治療市場：競爭格局
  • 癲癇治療市場：公司簡介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Service Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • GlaxoSmithKline plc.
  • Takeda Pharmaceutical Co. Ltd.
  • Medtronic plc
  • GE HealthCare Technologies Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Bausch Health Companies Inc.
  • UCB SA
  • Eisai Co. Ltd.
  • Sumitomo Dainippon Pharma Co. Ltd.
  • Dragerwerk AG & Co.KGaA
  • H. Lundbeck A/S
  • Apotex Inc.
  • Masimo Corporation
  • Fisher & Paykel Healthcare Limited
  • Inspiration Healthcare Group Plc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029 年癲癇治療市場：提供新機會的國家
  • 2029 年癲癇發作治療市場：細分市場帶來新機會
  • 2029 年癲癇治療市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r30155

Epileptic seizure treatment encompasses medical interventions and therapies aimed at managing and controlling seizures in individuals with epilepsy, a neurological disorder characterized by recurrent and unpredictable seizures. Treatment options may include medications, lifestyle modifications, dietary therapies, and other interventions tailored to each patient's specific needs, with the goal of reducing seizure frequency and severity and improving overall quality of life.

The main types of epileptic seizure treatment include established treatment practices, emerging drugs, and individualized therapies. Treatment practices involve methodologies used by healthcare professionals to manage symptoms, including pharmacological interventions, surgical procedures, and non-pharmacological therapies. These treatments address various seizure types, such as partial, generalized, and unclassified seizures, and can be administered via oral or buccal, nasal, rectal, or parenteral routes. Distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies.

The epileptic seizures treatment market research report is one of a series of new reports from The Business Research Company that provides epileptic seizures treatment market statistics, including epileptic seizures treatment industry global market size, regional shares, competitors with an epileptic seizures treatment market share, detailed epileptic seizures treatment market segments, market trends and opportunities, and any further data you may need to thrive in the epileptic seizures treatment industry. This epileptic seizures treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The epileptic seizures treatment market size has grown strongly in recent years. It will grow from $3.42 billion in 2024 to $3.66 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to advancements in antiepileptic drugs (AEDs), research breakthroughs in epilepsy treatment, increased awareness and education, expanded access to healthcare, and a rise in the prevalence of epilepsy.

The epileptic seizures treatment market size is expected to see strong growth in the next few years. It will grow to $4.72 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to precision medicine approaches, emerging therapeutic modalities, telemedicine and remote monitoring, healthcare integration and multidisciplinary care, and regulatory support and incentives. Major trends in the forecast period include personalized medicine, integration of digital health solutions, emerging therapeutic modalities, focus on comorbidities and quality of life, and regulatory support and market access.

The increasing incidence of epilepsy is anticipated to drive the growth of the market for treating epileptic seizures in the future. Epilepsy, a neurological disorder characterized by recurrent, unprovoked seizures, stems from abnormal electrical activity in the brain, leading to various symptoms such as convulsions, loss of consciousness, and sensory or behavioral disturbances. Factors contributing to the rising prevalence of epilepsy include improved survival rates among individuals with brain injuries or strokes and a growing elderly population. Effective treatment of epileptic seizures, primarily through antiepileptic drugs (AEDs), can significantly reduce their frequency and severity, thus ensuring patients' daily functioning and overall well-being. For instance, as of February 2024, the World Health Organization reported approximately 50 million people worldwide suffering from epilepsy, with about 5 million new diagnoses annually. Hence, the increasing incidence of epilepsy is fueling the expansion of the market for treating epileptic seizures.

Key players in the epileptic seizures treatment market are innovating to develop alternative treatment solutions, such as cannabis-based medications, particularly for patients unresponsive to traditional antiseizure drugs. Cannabis-based drugs, derived from the cannabis plant, harness the therapeutic properties of cannabinoids to address various medical conditions, including epilepsy, primarily for their anticonvulsant effects. For example, in January 2024, Akumentis Healthcare Ltd. introduced Clasepi, an orally administered cannabis plant-based medication approved by India's Drug Controller General to manage seizures, especially in children with conditions such as Lennox-Gastaut syndrome, Dravet syndrome, or Tuberous Sclerosis Complex. Clasepi, containing minimal tetrahydrocannabinol (THC) content, has shown efficacy in reducing seizures, particularly in cases where conventional treatments have proven ineffective, albeit it's cautioned for individuals allergic to cannabidiol or its constituents.

In March 2022, UCB SA bolstered its presence in the epileptic seizures treatment market by acquiring Zogenix Inc. for approximately $1.9 billion. This strategic move not only expands UCB's revenue potential but also grants access to promising epilepsy treatments, reinforcing its commitment to offering innovative solutions for severe forms of epilepsy such as Dravet syndrome. Zogenix Inc., a US-based biopharmaceutical company specializing in drugs and therapies for rare diseases, particularly rare pediatric epilepsy, thus enhances UCB's portfolio and strengthens its position in addressing the unmet medical needs of epilepsy patients.

Major companies operating in the epileptic seizures treatment market are Pfizer Inc., Johnson & Johnson Service Inc., Sanofi S.A., Abbott Laboratories, Novartis AG, GlaxoSmithKline plc., Takeda Pharmaceutical Co. Ltd., Medtronic plc, GE HealthCare Technologies Inc., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., UCB S.A., Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Dragerwerk AG & Co.KGaA, H. Lundbeck A/S, Apotex Inc., Masimo Corporation, Fisher & Paykel Healthcare Limited, Inspiration Healthcare Group Plc., Phoenix Medical Systems (P) Ltd., Marinus Pharmaceuticals Inc., Alexza Pharmaceuticals Inc., Neurelis Inc., Veriton Pharma

North America was the largest region in the epileptic seizures treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the epileptic seizures treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the epileptic seizures treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The epileptic seizures treatment market consists of revenues earned by entities by providing services, such as medication management, rehabilitation services, diagnostic services, telemedicine, and remote monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. The epileptic seizures treatment market also includes sales of anti-epileptic drugs, surgical implants, ketogenic diet products, seizure alarms, and vagus nerve stimulators which are used in providing the services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Epileptic Seizures Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on epileptic seizures treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for epileptic seizures treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The epileptic seizures treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Treatment Practices; Emerging Drugs; Individual Therapies
  • 2) By Seizure Type: Partial Seizures; Generalized Seizures; Unclassified Seizures
  • 3) By Route of Administration: Oral Or Buccal; Nasal; Rectal; Parenteral
  • 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
  • Subsegments:
  • 1) By Treatment Practices: Antiepileptic Drugs (AEDs); Surgery; Vagus Nerve Stimulation (VNS); Ketogenic Diet; Responsive Neurostimulation (RNS)
  • 2) By Emerging Drugs: New Antiepileptic Medications; Cannabidiol-based Drugs; Gene Therapy-Based Treatments; Monoclonal Antibodies
  • 3) By Individual Therapies: Monotherapy; Combination Therapy; Adjunctive Therapy
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson Service Inc.; Sanofi S.A.; Abbott Laboratories; Novartis AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Epileptic Seizures Treatment Market Characteristics

3. Epileptic Seizures Treatment Market Trends And Strategies

4. Epileptic Seizures Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Epileptic Seizures Treatment Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Epileptic Seizures Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Epileptic Seizures Treatment Market Growth Rate Analysis
  • 5.4. Global Epileptic Seizures Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Epileptic Seizures Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Epileptic Seizures Treatment Total Addressable Market (TAM)

6. Epileptic Seizures Treatment Market Segmentation

  • 6.1. Global Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Treatment Practices
  • Emerging Drugs
  • Individual Therapies
  • 6.2. Global Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Partial Seizures
  • Generalized Seizures
  • Unclassified Seizures
  • 6.3. Global Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral Or Buccal
  • Nasal
  • Rectal
  • Parenteral
  • 6.4. Global Epileptic Seizures Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • 6.5. Global Epileptic Seizures Treatment Market, Sub-Segmentation Of Treatment Practices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Antiepileptic Drugs (AEDs)
  • Surgery
  • Vagus Nerve Stimulation (VNS)
  • Ketogenic Diet
  • Responsive Neurostimulation (RNS)
  • 6.6. Global Epileptic Seizures Treatment Market, Sub-Segmentation Of Emerging Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • New Antiepileptic Medications
  • Cannabidiol-based Drugs
  • Gene Therapy-Based Treatments
  • Monoclonal Antibodies
  • 6.7. Global Epileptic Seizures Treatment Market, Sub-Segmentation Of Individual Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Monotherapy
  • Combination Therapy
  • Adjunctive Therapy

7. Epileptic Seizures Treatment Market Regional And Country Analysis

  • 7.1. Global Epileptic Seizures Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Epileptic Seizures Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Epileptic Seizures Treatment Market

  • 8.1. Asia-Pacific Epileptic Seizures Treatment Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Epileptic Seizures Treatment Market

  • 9.1. China Epileptic Seizures Treatment Market Overview
  • 9.2. China Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Epileptic Seizures Treatment Market

  • 10.1. India Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Epileptic Seizures Treatment Market

  • 11.1. Japan Epileptic Seizures Treatment Market Overview
  • 11.2. Japan Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Epileptic Seizures Treatment Market

  • 12.1. Australia Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Epileptic Seizures Treatment Market

  • 13.1. Indonesia Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Epileptic Seizures Treatment Market

  • 14.1. South Korea Epileptic Seizures Treatment Market Overview
  • 14.2. South Korea Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Epileptic Seizures Treatment Market

  • 15.1. Western Europe Epileptic Seizures Treatment Market Overview
  • 15.2. Western Europe Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Epileptic Seizures Treatment Market

  • 16.1. UK Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Epileptic Seizures Treatment Market

  • 17.1. Germany Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Epileptic Seizures Treatment Market

  • 18.1. France Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Epileptic Seizures Treatment Market

  • 19.1. Italy Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Epileptic Seizures Treatment Market

  • 20.1. Spain Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Epileptic Seizures Treatment Market

  • 21.1. Eastern Europe Epileptic Seizures Treatment Market Overview
  • 21.2. Eastern Europe Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Epileptic Seizures Treatment Market

  • 22.1. Russia Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Epileptic Seizures Treatment Market

  • 23.1. North America Epileptic Seizures Treatment Market Overview
  • 23.2. North America Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Epileptic Seizures Treatment Market

  • 24.1. USA Epileptic Seizures Treatment Market Overview
  • 24.2. USA Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Epileptic Seizures Treatment Market

  • 25.1. Canada Epileptic Seizures Treatment Market Overview
  • 25.2. Canada Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Epileptic Seizures Treatment Market

  • 26.1. South America Epileptic Seizures Treatment Market Overview
  • 26.2. South America Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Epileptic Seizures Treatment Market

  • 27.1. Brazil Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Epileptic Seizures Treatment Market

  • 28.1. Middle East Epileptic Seizures Treatment Market Overview
  • 28.2. Middle East Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Epileptic Seizures Treatment Market

  • 29.1. Africa Epileptic Seizures Treatment Market Overview
  • 29.2. Africa Epileptic Seizures Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Epileptic Seizures Treatment Market, Segmentation By Seizure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Epileptic Seizures Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Epileptic Seizures Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Epileptic Seizures Treatment Market Competitive Landscape
  • 30.2. Epileptic Seizures Treatment Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson & Johnson Service Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Epileptic Seizures Treatment Market Other Major And Innovative Companies

  • 31.1. GlaxoSmithKline plc.
  • 31.2. Takeda Pharmaceutical Co. Ltd.
  • 31.3. Medtronic plc
  • 31.4. GE HealthCare Technologies Inc.
  • 31.5. Teva Pharmaceutical Industries Ltd.
  • 31.6. Bausch Health Companies Inc.
  • 31.7. UCB S.A.
  • 31.8. Eisai Co. Ltd.
  • 31.9. Sumitomo Dainippon Pharma Co. Ltd.
  • 31.10. Dragerwerk AG & Co.KGaA
  • 31.11. H. Lundbeck A/S
  • 31.12. Apotex Inc.
  • 31.13. Masimo Corporation
  • 31.14. Fisher & Paykel Healthcare Limited
  • 31.15. Inspiration Healthcare Group Plc.

32. Global Epileptic Seizures Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Epileptic Seizures Treatment Market

34. Recent Developments In The Epileptic Seizures Treatment Market

35. Epileptic Seizures Treatment Market High Potential Countries, Segments and Strategies

  • 35.1 Epileptic Seizures Treatment Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Epileptic Seizures Treatment Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Epileptic Seizures Treatment Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer